本文首发于公众号"私募排排网"。 （点击↑↑ 上图查看详情 ） 丹羿投资成立于2015年4月，荣获金牛奖、英华奖、金长江奖等业内各大重磅奖项，至今已经历十年牛熊转换，由曾经的公募"明星基金经理"朱 亮创立，目前公司员工19位。公司秉持 "长期视角，早期介入，寻找十年后的茅台 " 的投资理念，聚焦高端制造、消费、科技、医药等几大板 块，潜心耕耘。 私募排排网数据显示，截至8月底，丹羿投资旗下有业绩显示的5只产品，今年来收益均值为 ***% ，位居20-50亿私募第8位。值得关注的是， 基金经理王帅 管理的 "丹羿鹏程1号1期"今年来以 ***% 的翻倍式收益，在 20-50亿私募1-8月主观多头产品中位居第2。（ 点此查看收益 ） [应监管要求，私募产品不能公开展示业绩，文中涉及收益数据用***替代，合格投资者可扫码查看收益数据。] | 排名 | 产品简称 | 公司简称 | 章等经理 | 成立日期 | 产品规模(万元) | 今年来收益 | | --- | --- | --- | --- | --- | --- | --- | | 1 | 歌汝奇点 | 上海歌汝私 블 | 石浩 | 2022/3/3 | | | ...

Core Viewpoint - The A-share market has shown a strong performance, with the Shanghai Composite Index reaching 3700 points, indicating a recovery from previous economic shocks. A trend of gradual growth has emerged since April 27, following the impact of U.S. tariffs, leading to a widening gap between stock strategies and other primary strategies [1]. Summary by Categories Market Performance - The A-share market has entered a four-month trend of gradual growth, with a noticeable recovery in the index [1]. - Quantitative long strategies and subjective long strategies have both performed well, with quantitative long strategies achieving a return of 25.02% and subjective long strategies averaging 5.86% in July [3][4]. Strategy Performance - Among various strategies, subjective long strategies have outperformed quantitative long strategies due to their concentrated positions and flexibility in trading [4]. - The average return for subjective long strategies across different scales of private equity funds has been significant, with the highest returns observed in the 10-20 billion category at 25.43% [18]. Fund Performance - The top-performing subjective long products in the 100 billion category include "和谐汇一医疗创新B类份额" managed by 施跃, achieving a return of ***% [7][5]. - In the 50-100 billion category, "同犇22期" managed by 童驯 led with a return of ***% [14]. - The 20-50 billion category saw "丹羿鹏程1号1期" managed by 王帅 achieving a return of ***% [17]. - In the 10-20 billion category, "能敬价值优选二号" managed by 孙杰 led with a return of ***% [21]. - The 5-10 billion category was topped by "优波三号A类份额" managed by 陈龙 with a return of ***% [24]. - The 0-5 billion category saw "子衿云杉" managed by 邹凯 achieving a return of ***% [28]. Investment Insights - Fund managers are focusing on sectors such as innovative pharmaceuticals and medical devices, indicating a re-evaluation of high-quality assets in China [8]. - The market is currently in a phase where investors are cautious about the sustainability of earnings for companies that have seen significant price increases [8].